Floatz logo

Bendamustine

Stage IV Prostate Cancer AJCC v8

Fred Hutchinson Cancer CenterSmall moleculePhase 1/2Active
CCC
52/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
40/ 100
Competitive Position
89/ 100

Competitive context

14 Active assets in the Stage IV Prostate Cancer AJCC v8 cohort.

Asset / SponsorPhaseRating
Bet Bromodomain Inhibitor Zen-3694
Rahul Aggarwal
Phase 2B
Rucaparib
Alliance for Clinical Trials in Oncology
Phase 3B
vx-970
National Cancer Institute (NCI)
Phase 2CCC
PAN-FGFR TYROSINE KINASE INHIBITOR JNJ-42756493
M.D. Anderson Cancer Center
Phase 2CCC
Golimumab
University of Washington
Phase 2CCC

View all 31 →

Same molecule, other indications

Bendamustine is also rated in:

mantle cell lymphomaDormant
BBB
Indicative ·
74 / 100
View asset →
Hodgkins lymphomaDormant
BBB
Indicative ·
73 / 100
View asset →
diffuse large B-cell lymphomaDormant
BB
Indicative ·
71 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →